skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 15,501  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Medical Prognosis remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
256 Prognostic factors of survival and recurrence of paget’s disease of the breast: a study of 58 cases
256 Prognostic factors of survival and recurrence of paget’s disease of the breast: a study of 58 cases
Material Type:
Article 		Add to My Research

256 Prognostic factors of survival and recurrence of paget’s disease of the breast: a study of 58 cases

International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A104-A104 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-IGCS.221

Full text available

Citations Cited by
2
S2085 Rare Case of Small Cell Carcinoma of the Rectum
S2085 Rare Case of Small Cell Carcinoma of the Rectum
Material Type:
Article 		Add to My Research

S2085 Rare Case of Small Cell Carcinoma of the Rectum

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e1422-e1423 [Peer Reviewed Journal]

2022 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000864980.20014.37

Full text available

Citations Cited by
3
EP171/#796  The need for lymph node evaluation in late-stage uterine carcinosarcoma – a multicenter retrospective study
EP171/#796  The need for lymph node evaluation in late-stage uterine carcinosarcoma – a multicenter retrospective study
Material Type:
Article 		Add to My Research

EP171/#796  The need for lymph node evaluation in late-stage uterine carcinosarcoma – a multicenter retrospective study

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A147-A147 [Peer Reviewed Journal]

IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-IGCS.261

Full text available

Citations Cited by
4
S1649 Small Cell Carcinoma of Gallbladder: A Report of a Rare and Unfortunate Case
S1649 Small Cell Carcinoma of Gallbladder: A Report of a Rare and Unfortunate Case
Material Type:
Article 		Add to My Research

S1649 Small Cell Carcinoma of Gallbladder: A Report of a Rare and Unfortunate Case

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S739-S739 [Peer Reviewed Journal]

2021 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000780128.95070.b6

Full text available

Citations Cited by
5
125 Intracystic papillary carcinoma of the breast : a single institution experience
125 Intracystic papillary carcinoma of the breast : a single institution experience
Material Type:
Conference Proceeding 		Add to My Research

125 Intracystic papillary carcinoma of the breast : a single institution experience

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A216-A216 [Peer Reviewed Journal]

2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-ESGO.447

Full text available

Citations Cited by
6
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
Material Type:
Article 		Add to My Research

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study

The lancet oncology, 2019-09, Vol.20 (9), p.1239-1251 [Peer Reviewed Journal]

Elsevier Ltd ;2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30388-2 ;PMID: 31345627

Full text available

Citations Cited by
7
209 Prognostic factors related to recurrence and survival of ­early stage vulvar squamous cell carcinoma
209 Prognostic factors related to recurrence and survival of ­early stage vulvar squamous cell carcinoma
Material Type:
Article 		Add to My Research

209 Prognostic factors related to recurrence and survival of ­early stage vulvar squamous cell carcinoma

International journal of gynecological cancer, 2020-12, Vol.30 (Suppl 4), p.A103-A103 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-ESGO.179

Full text available

Citations Cited by
8
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
Material Type:
Article 		Add to My Research

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

The lancet oncology, 2021-08, Vol.22 (8), p.1081-1092 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00297-7

Full text available

Citations Cited by
9
2022-RA-1647-ESGO Impact of tumor volume on survival of patients with lymph node metastasis in endometrial cancer
2022-RA-1647-ESGO Impact of tumor volume on survival of patients with lymph node metastasis in endometrial cancer
Material Type:
Article 		Add to My Research

2022-RA-1647-ESGO Impact of tumor volume on survival of patients with lymph node metastasis in endometrial cancer

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A166-A167 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2022-ESGO.358

Full text available

Citations Cited by
10
2022-VA-1166-ESGO Suspicious lymph nodes in advanced ovarian cancer: debulking surgery
2022-VA-1166-ESGO Suspicious lymph nodes in advanced ovarian cancer: debulking surgery
Material Type:
Article 		Add to My Research

2022-VA-1166-ESGO Suspicious lymph nodes in advanced ovarian cancer: debulking surgery

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A307-A308 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2022-ESGO.655

Full text available

Citations Cited by
11
2022-RA-955-ESGO Endometrial cancer: lymphovascular space invasion is a negative prognostic factor
2022-RA-955-ESGO Endometrial cancer: lymphovascular space invasion is a negative prognostic factor
Material Type:
Article 		Add to My Research

2022-RA-955-ESGO Endometrial cancer: lymphovascular space invasion is a negative prognostic factor

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A122-A122 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2022-ESGO.264

Full text available

Citations Cited by
12
2022-RA-860-ESGO Isolated lymph node recurrence in epithelial ovarian cancer- management and outcome
2022-RA-860-ESGO Isolated lymph node recurrence in epithelial ovarian cancer- management and outcome
Material Type:
Article 		Add to My Research

2022-RA-860-ESGO Isolated lymph node recurrence in epithelial ovarian cancer- management and outcome

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A270-A270 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2022-ESGO.577

Full text available

Citations Cited by
13
2022-RA-987-ESGO Molecular characterization of endometrial cancer with low volume metastasis in the sentinel lymph node: a multicentric international study
2022-RA-987-ESGO Molecular characterization of endometrial cancer with low volume metastasis in the sentinel lymph node: a multicentric international study
Material Type:
Article 		Add to My Research

2022-RA-987-ESGO Molecular characterization of endometrial cancer with low volume metastasis in the sentinel lymph node: a multicentric international study

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A124-A124 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2022-ESGO.268

Full text available

Citations Cited by
14
2022-RA-1246-ESGO The impact on survival of FDG-TEP versus surgical pretherapeutic paraaortic lymph node staging in locally advanced cervical cancer before concomitant chemoradiation. A retrospective single-center cohort
2022-RA-1246-ESGO The impact on survival of FDG-TEP versus surgical pretherapeutic paraaortic lymph node staging in locally advanced cervical cancer before concomitant chemoradiation. A retrospective single-center cohort
Material Type:
Article 		Add to My Research

2022-RA-1246-ESGO The impact on survival of FDG-TEP versus surgical pretherapeutic paraaortic lymph node staging in locally advanced cervical cancer before concomitant chemoradiation. A retrospective single-center cohort

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A49-A49 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2022-ESGO.107

Full text available

Citations Cited by
15
2022-RA-586-ESGO The impact of the pattern of recurrence on post-relapse survival according to surgical timing in patients with advanced ovarian cancer
2022-RA-586-ESGO The impact of the pattern of recurrence on post-relapse survival according to surgical timing in patients with advanced ovarian cancer
Material Type:
Article 		Add to My Research

2022-RA-586-ESGO The impact of the pattern of recurrence on post-relapse survival according to surgical timing in patients with advanced ovarian cancer

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A240-A240 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2022-ESGO.517

Full text available

Citations Cited by
16
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
Material Type:
Article 		Add to My Research

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

The lancet oncology, 2018-10, Vol.19 (10), p.1385-1393 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 2018 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30380-2 ;PMID: 30196031

Full text available

Citations Cited by
17
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Material Type:
Article 		Add to My Research

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

The Lancet (British edition), 2022-04, Vol.399 (10336), p.1695-1707 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00367-1 ;PMID: 35405085

Full text available

Citations Cited by
18
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
Material Type:
Article 		Add to My Research

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

The Lancet (British edition), 2022-04, Vol.399 (10335), p.1607-1617 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02333-3 ;PMID: 35461558

Full text available

Citations Cited by
19
METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance
METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance
Material Type:
Article 		Add to My Research

METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance

Gut, 2020-07, Vol.69 (7), p.1193-1205 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2019-319639

Full text available

Citations Cited by
20
EP551 A clinicopathologic characteristics and prognosis comparison between uterine carcinosarcomas and uterine high grade endometrial carcinomas
EP551 A clinicopathologic characteristics and prognosis comparison between uterine carcinosarcomas and uterine high grade endometrial carcinomas
Material Type:
Article 		Add to My Research

EP551 A clinicopathologic characteristics and prognosis comparison between uterine carcinosarcomas and uterine high grade endometrial carcinomas

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A334-A334 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-ESGO.608

Full text available

Citations Cited by

Results 1 - 20 of 15,501  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (13,932)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1988  (13)
  2. 1988 To 1996  (35)
  3. 1997 To 2005  (260)
  4. 2006 To 2015  (2,128)
  5. After 2015  (13,066)
  6. More options open sub menu

Subject 

  1. Lymphatic System  (15,498)
  2. Science & Technology  (13,708)
  3. Life Sciences & Biomedicine  (12,896)
  4. Metastasis  (11,787)
  5. Patients  (8,670)
  6. Tumors  (8,494)
  7. Oncology  (8,159)
  8. Chemotherapy  (6,547)
  9. Cancer Therapies  (6,532)
  10. Surgery  (6,059)
  11. Humans  (5,981)
  12. Prognosis  (5,902)
  13. Cancer  (4,933)
  14. Female  (4,008)
  15. Metastases  (3,647)
  16. Care And Treatment  (3,575)
  17. Radiation Therapy  (3,506)
  18. Lymph Nodes  (3,302)
  19. Middle Aged  (3,182)
  20. More options open sub menu

Language 

  1. English  (15,402)
  2. Japanese  (1,262)
  3. Chinese  (106)
  4. Turkish  (81)
  5. French  (17)
  6. Portuguese  (10)
  7. Polish  (9)
  8. Norwegian  (9)
  9. German  (3)
  10. Spanish  (2)
  11. Ukrainian  (1)
  12. Romanian  (1)
  13. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait